Cancer genetics, inc (CGIX)
Income statement / Yearly
Dec'18Dec'17Dec'16Dec'15Dec'14Dec'13Dec'12Dec'11
Revenue

27,470

29,121

-

-

-

-

-

-

Revenue

-

-

27,049

18,040

10,199

6,610

4,301

3,019

Cost of revenues

18,724

18,070

17,104

14,098

8,453

4,925

3,928

3,117

Gross profit (loss)

8,746

11,051

9,945

3,942

1,746

1,685

372

-98

Operating expenses:
Research and development

2,488

4,789

5,967

5,483

4,622

2,190

2,111

2,073

General and administrative

19,184

19,894

16,034

14,567

12,369

6,115

4,502

4,439

Sales and marketing

5,268

4,990

4,668

5,269

3,964

1,842

1,398

1,574

Restructuring costs

2,320

0

-

-

-

-

-

-

Merger costs

1,464

0

-

-

-

-

-

-

Total operating expenses

30,724

29,673

26,669

25,319

20,955

10,147

8,013

8,086

Loss from continuing operations

-21,978

-18,622

-16,724

-21,377

-19,209

-8,462

-7,640

-8,184

Other income (expense):
Interest expense

2,120

2,128

454

344

473

2,388

4,701

1,314

Business Combination, Contingent Consideration Arrangements, Change in Amount of Contingent Consideration, Liability

-136

42

-152

-269

-198

0

0

-

Change in fair value of other derivatives

-86

0

-

-

-

-

-

-

Interest income

21

63

23

49

74

30

0

0

Change in fair value of warrant liability

3,732

-1,964

1,525

35

417

4,633

7,538

-10,388

Other expense

78

266

325

0

-

-

-

-

Loss on debt and warrant restructuring

-

-

-

-

-

-

-1,862

-

Debt conversion costs

-

-

-

-

0

6,850

0

-

Total other income (expense)

1,605

-4,337

921

9

216

-4,575

974

-11,702

Loss before income taxes

-20,373

-22,959

-15,803

-21,368

-18,993

-13,037

-6,665

-19,887

Income tax benefit

0

-2,079

0

-1,184

-2,350

-664

0

-

Net Income (Loss) Attributable to Parent

-20,373

-20,880

-15,803

-20,184

-16,643

-12,373

-6,665

-19,887

Basic net (loss) per share (in dollars per share)

-

-

-

-1.96

-1.76

-2.65

-4.97

-15.61

Diluted net (loss) per share (in dollars per share)

-

-

-

-1.96

-1.80

-3.64

-10.55

-15.61

Basic weighted-average shares outstanding (in shares)

-

-

-

10,298

9,449

4,665

1,342

1,274

Diluted weighted-average shares outstanding (in shares)

-

-

-

10,299

9,462

4,676

1,346

1,274

Unrealized gain (loss) on foreign currency translation

-9

69

0

-

-

-

-

-

Comprehensive income (loss)

-20,382

-20,811

-15,803

-

-

-

-

-

Basic and diluted net income (loss) per share (usd per share)

-0.75

-1.01

-1.00

-

-

-

-

-

Basic and diluted weighted-average shares outstanding

27,291

20,663

15,861

-

-

-

-

-